Wasiulla Khan - Janssen Sci Affairs LLC

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 13 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results from the Final Analysis of the Prospective, Observational, Informcll Registry

Nilanjan Ghosh,Jeff P. Sharman,Meghan Gutierrez,Wasiulla Khan,Zaina P. Qureshi,Anat Raz,Vincent Girardi,Gabriel S. Krigsfeld,Jacqueline C. Barrientos

CLINICAL LYMPHOMA MYELOMA & LEUKEMIAno. 9 (2024): e301-e313

引用0浏览0WOS引用

Overall Survival of Patients with Chronic Lymphocytic Leukemia Treated with Frontline Bruton's Tyrosine Kinase Inhibitors: an Analysis of the United States Veterans Health Administration Database

Lindsey Fitzgerald,Wasiulla Khan,Alex Bokun,Angela Lax, Fan Mu, Yilu Lin, Lizheng Shi, Zaina P Qureshi, Solomon Graf

Bloodno. Supplement 1 (2024): 7753-7753

引用0浏览0引用

Time to Next Treatment in Patients with Chronic Lymphocytic Leukemia Initiating First-Line Ibrutinib or Acalabrutinib

Ryan Jacobs,Xiaoxiao Lu,Bruno Emond,Laura Morrison,Frederic Kinkead,Patrick Lefebvre,Marie-Helene Lafeuille,Wasiulla Khan,Linda H. Wu,Zaina P. Qureshi,Moshe Yair Levy

FUTURE ONCOLOGYno. 1 (2024): 39-53

引用0浏览0WOS引用

Real-world characteristics and outcomes of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with long-term ibrutinib: results from the prospective, observational informCLL Registry

Nilanjan Ghosh,Jacqueline Barrientos,Meghan Gutierrez,Zaina Qureshi,Wasiulla Khan,Anat Raz,Vincent Girardi,Gabriel Krigsfeld,Jeff Sharman

LEUKEMIA & LYMPHOMA (2023): S61-S62

引用0浏览0引用

Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia

Xiaoxiao Lu,Bruno Emond,Laura Morrison,Frederic Kinkead,Patrick Lefebvre,Marie-Helene Lafeuille,Wasiulla Khan,Linda H. Wu,Zaina P. Qureshi,Ryan Jacobs

PATIENT PREFERENCE AND ADHERENCE（2023）

引用0浏览0WOS引用

Tailor: Interventional Study Evaluating Physician's Choice of Ibrutinib Monotherapy or Ibrutinib-Venetoclax Combination Using Dose Modifications and Alternate Dosing Approaches in Patients with Untreated Chronic Lymphocytic Leukemia

Jeff P. Sharman,Jan A. Burger,Jacqueline Barrientos,Philip Kuruvilla,Sima Patel,Gabriel Krigsfeld,Sowmya Srikanthan, Bothayna Messahel,Wasiulla Khan, Emma Smith,Paolo Ghia

BLOOD (2023)

引用0浏览0引用

Benefit of Continuing Luspatercept Therapy in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Who Did Not Achieve Red Blood Cell Transfusion Independence (RBC-TI) by Week 25 in the MEDALIST Study

Uwe Platzbecker,Ulrich Germing,Pierre Fenaux,Rena Buckstein,Valeria Santini,Maria Diez-Campelo,Derek Tang,Rodrigo Ito,Shannon Fabre,Emily Mantovani,George Zhang,Xianwei Ha,Dimana Miteva,Christina Hughes,Wasiulla Khan,Rami S. Komrokji,Guillermo Garcia-Manero

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 3 (2022): 142-143

引用0浏览0引用

Luspatercept Reduces Red Blood Cell Transfusions (RBCT) in Patients with Lower-Risk Myelodysplastic Syndromes (LRMDS) Regardless of Baseline Transfusion Burden (TB) in the MEDALIST Study

Uwe Platzbecker,Guillermo Garcia-Manero,Pierre Fenaux,Rena Buckstein,Valeria Santini,Maria Diez-Campelo,Derek Tang,Rodrigo Ito,Shannon Fabre,Emily Mantovani,Roberto Zoffoli,Dimana Miteva,Christina Hughes,Wasiulla Khan,Rami S. Komrokji,Ulrich Germing

ONCOLOGY RESEARCH AND TREATMENT（2022）

引用0浏览0引用

Real World Treatment Patterns in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Switching from First Line Ibrutinib to Acalabrutinib

Ryan Jacobs,Ruibin Wang,Jinghua He,Xiaoxiao Lu,Linda Wu,Wasiulla Khan,Zaina P. Qureshi,Moshe Yair Levy

Blood（2022）

引用1浏览0引用

Real-World Comparison of Time to Next Treatment for Patients with CLL Initiated on First-Line Treatment with Ibrutinib Versus Acalabrutinib

Ryan Jacobs,Xiaoxiao Lu,Bruno Emond,Laura Morrison,Frédéric Kinkead,Patrick Lefebvre,Marie-Hélène Lafeuille,Wasiulla Khan,Linda Wu,Zaina P. Qureshi,Moshe Yair Levy

Blood（2022）

引用2浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn